CryoCath to present at Piper Jaffray and BMO Healthcare conferences



    Toronto Stock Exchange Symbol: CYT

    MONTREAL, Nov. 27 /CNW/ - CryoCath Technologies Inc. (TSX: CYT), the
global leader in cryotherapy products to treat cardiac arrhythmias, today
announced that Jan Keltjens, President and CEO of CryoCath, will present at
both the Piper Jaffray 19th Annual Health Care Conference and the BMO Focus on
Healthcare Conference. The Piper Jaffray Conference presentation will take
place today at 1:50 pm ET at the Pierre Hotel in New York City and the BMO
Conference will take place on Wednesday, December 5 at 2:00 pm ET at the
Millenium Broadway Hotel in New York City. Both events will feature a market
outlook and discuss some recent events and upcoming milestones, including the
STOP AF IDE Trial for Arctic Front(R), the Company's minimally invasive
cryo-balloon catheter designed specifically to treat paroxysmal atrial
fibrillation.
    The BMO Focus on Healthcare Conference will be accompanied by a live
webcast of Mr. Keltjens' presentation, available at www.cryocath.com.

    About CryoCath

    CryoCath - www.cryocath.com - is a medical technology company that leads
the world in cryotherapy products to treat cardiovascular disease. With a
priority focus on providing physicians with a complete solution of catheter
products to treat cardiac arrhythmias, CryoCath has multiple products approved
in the U.S., across Europe and several ROW countries. The Company is
developing additional products to expand its pipeline of products to treat
cardiac arrhythmias.

    This press release includes "forward-looking statements" that are subject
to risks and uncertainties, including with respect to the timing of regulatory
trials and their outcome. For information identifying legislative or
regulatory, economic, climatic, currency, technological, competitive and other
important factors that could cause actual results to differ materially from
those anticipated in the forward looking statements, see CryoCath's annual
report available at www.sedar.com under the heading Risks and Uncertainties in
the Management's Discussion and Analysis section.

    %SEDAR: 00015053EF




For further information:

For further information: visit our website at www.cryocath.com, or
contact: Michael Moore, Investor Relations, Phone: (416) 815-0700 ext. 241,
Fax: (416) 815-0080, E-mail: mmoore@equicomgroup.com

Organization Profile

CRYOCATH TECHNOLOGIES INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890